IRIS

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis / Sands, Be; Sandborn, Wj; Panaccione, R; O'Brien, Cd; Zhang, H; Johanns, J; Adedokun, Oj; Li, K; Peyrin-Biroulet, L; Van Assche, G; Danese, S; Targan, S; Abreu, Mt; Hisamatsu, T; Szapary, P; Marano, C. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 381:13(2019), pp. 1201-1214. [10.1056/NEJMoa1900750]

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Danese S;
2019-01-01
2019
381
13
1201
1214
14
2-s2.0-85072655728
WOS:000489333500005
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis / Sands, Be; Sandborn, Wj; Panaccione, R; O'Brien, Cd; Zhang, H; Johanns, J; Adedokun, Oj; Li, K; Peyrin-Biroulet, L; Van Assche, G; Danese, S; Targan, S; Abreu, Mt; Hisamatsu, T; Szapary, P; Marano, C. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 381:13(2019), pp. 1201-1214. [10.1056/NEJMoa1900750]
none
16
info:eu-repo/semantics/article
262
Sands, Be; Sandborn, Wj; Panaccione, R; O'Brien, Cd; Zhang, H; Johanns, J; Adedokun, Oj; Li, K; Peyrin-Biroulet, L; Van Assche, G; Danese, S; Targan, ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119870
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1053
  • ???jsp.display-item.citation.isi??? 986
social impact